Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (2)
  • Akt
    (2)
  • Calcium Channel
    (2)
  • Antibacterial
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • COX
    (1)
  • CaMK
    (1)
  • Estrogen Receptor/ERR
    (1)
  • Others
    (5)
Filter
Search Result
Results for "

osteoblastic

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
  • Natural Products
    10
    TargetMol | Natural_Products
  • Recombinant Protein
    4
    TargetMol | Recombinant_Protein
Sciadopitysin
T5S2129521-34-6
Sciadopitysin may prevent the development of diabetic osteopathy, it exerts its therapeutic effects via upregulation of mitochondrial biogenesis.Sciadopitysin shows protective effects on antimycin A-induced toxicity in osteoblastic MC3T3-E1 cells, it may
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Psoralenoside
TN1008905954-17-8
Psoralenoside is a natural product isolated from the fruits of Psoralea corylifolia, shows estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity.
  • Inquiry Price
Size
QTY
Isopsoralenoside
TN1148905954-18-9
Isopsoralenoside shows estrogen-like, osteoblastic proliferation accelerating, antitumor, and antibacterial effects.
  • Inquiry Price
Size
QTY
Caesappanin C
T135891913319-59-1
Caesappanin C, extracted from the heartwood of Indonesian Caesalpinia sappan L., shows strong proliferation stimulating activity against the primary osteoblastic cells in vitro.
  • Inquiry Price
Size
QTY
Tigogenin
T575177-60-1
Tigogenin is one of steroidal sapogenins which is widely used for synthesizing steroid drugs. It might have protective effect on bone and be helpful in preventing the development of osteoporosis.
  • Inquiry Price
Size
QTY
Actein
T719018642-44-9
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblasts in osteoporotic patients. Actein's ability to pathways involved in lipid disorders and carci
  • Inquiry Price
Size
QTY
1-Hydroxy-2,3,4,7-tetramethoxyxanthone
TN253314103-09-4
1-Hydroxy-2,3,4,7-tetramethoxyxanthone, with an EC50 value of 6.6±1.4 µM, has vasodilatory action in coronary arteries pre-contracted with 1 µM 5-hydroxytryptamine (5-HT) and can effectively inhibit osteoclast differentiation in a co-culture system with mouse osteoblastic calvarial cells and bone marrow cells.
  • Inquiry Price
Size
QTY
1-Hydroxy-2,3,5-trimethoxyxanthone
TN253422804-49-5
1-Hydroxy-2,3,5-trimethoxyxanthone (HM-1) exhibits vasodilator action through an endothelium-dependent mechanism involving NO and an endothelium-independent mechanism by inhibiting Ca(2+) influx via L-type voltage-operated Ca(2+) channels. A minor contribution to HM-1's effects may stem from inhibiting protein kinase C-mediated release of intracellular Ca(2+) stores. At 1 µg mL, HM-1 effectively inhibits osteoclast differentiation in co-cultures with mouse osteoblastic calvarial and bone marrow cells and protects mice from acute lung injury induced by lipopolysaccharide (LPS), likely by increasing IκB-α protein expression and suppressing inducible nitric oxide synthase and cyclooxygenase-Ⅱ protein expression.
  • Inquiry Price
Size
QTY
Dalbergioidin
TN375330368-42-4
Dalbergioidin exhibits tyrosinase inhibitory activity with an IC50 of 20 mM. It shows a melanin biosynthesis inhibition zone in the culture plate of Streptomyces bikiniensis that has commonly been used as an indicator organism. Dalbergioidin protects MC3T3-E1 osteoblastic cells against H2O2-induced cell damage through activation of the PI3K AKT SMAD1 pathway, suggests that it may be useful in bone metabolism diseases, particularly osteoporosis. Dalbergioidin also ameliorates doxorubicin-induced renal fibrosis by suppressing the TGF-β signal pathway.
  • Inquiry Price
7-10 days
Size
QTY
Dalbergiphenol
TN375452811-31-1
Dalbergiphenol shows antiosteoporotic activity, dalbergiphenol treatment can effectively prevent OVX-induced increase in bone loss and decrease in bone strength possibly by increasing osteoblastic activities and by decreasing osteoclastic activities.
  • Inquiry Price
Size
QTY